Valion Bio, Inc. (VBIO) Operating income 2021–2025
Valion Bio, Inc. (VBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$7.9MFY2025 · since FY2021: -$5.6M → -$7.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.9M | -76.5% |
| FY2024 | -$4.5M | +45.7% |
| FY2023 | -$8.2M | +18.4% |
| FY2022 | -$10.1M | -79.3% |
| FY2021 | -$5.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice